[HTML][HTML] Transcatheter aortic valve replacement in low risk patients: a review of PARTNER 3 and Evolut low risk trials

J Braghiroli, K Kapoor, TP Thielhelm… - Cardiovascular …, 2020 - ncbi.nlm.nih.gov
Transcatheter aortic valve replacement (TAVR) has become a mainstay in treatment for
patients with severe aortic stenosis who are considered high-risk surgical candidates. The …

Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical …

HGH Thyregod, DA Steinbrüchel, N Ihlemann… - Journal of the American …, 2015 - jacc.org
Background: Transcatheter aortic valve replacement (TAVR) is an option in certain high-risk
surgical patients with severe aortic valve stenosis. It is unknown whether TAVR can be …

Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis

R Waksman, T Rogers, R Torguson, P Gordon… - Journal of the American …, 2018 - jacc.org
Background: Transcatheter aortic valve replacement (TAVR) is now the standard of care for
patients with symptomatic severe aortic stenosis who are extreme, high, or intermediate risk …

[HTML][HTML] Expansion of TAVR into low-risk patients and who to consider for SAVR

KV Patel, W Omar, PE Gonzalez, ME Jessen… - Cardiology and …, 2020 - Springer
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of severe
aortic stenosis (AS) over the last decade. The results of the Placement of Aortic …

Comparison of outcomes after transcatheter aortic valve replacement vs surgical aortic valve replacement among patients with aortic stenosis at low operative risk

MPO Virtanen, M Eskola, MP Jalava, A Husso… - JAMA network …, 2019 - jamanetwork.com
Importance Transcatheter aortic valve replacement (TAVR) has been shown to be a valid
alternative to surgical aortic valve replacement (SAVR) in patients at high operative risk with …

Transcatheter vs surgical aortic valve replacement for aortic stenosis in low-intermediate risk patients: a meta-analysis

DY Tam, TX Vo, HC Wijeysundera, DT Ko… - Canadian Journal of …, 2017 - Elsevier
Background Transcatheter aortic valve replacement (TAVR) has emerged as the treatment
of choice for patients with severe aortic stenosis at high surgical risk; the role of TAVR …

2-year outcomes after transcatheter versus surgical aortic valve replacement in low-risk patients

JK Forrest, GM Deeb, SJ Yakubov, JD Rovin… - Journal of the American …, 2022 - jacc.org
Abstract Background The Evolut Low Risk Trial (Medtronic Evolut Transcatheter Aortic Valve
Replacement in Low Risk Patients) showed that transcatheter aortic valve replacement …

Transcatheter versus surgical aortic valve replacement in intermediate‐risk patients: Evidence from a meta‐analysis

P Sardar, A Kundu, S Chatterjee… - Catheterization and …, 2017 - Wiley Online Library
Objectives We performed a meta‐analysis to evaluate the efficacy and safety of
transcatheter aortic valve replacement (TAVR) in comparison to surgical aortic valve …

[HTML][HTML] Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a comprehensive meta-analysis

A Elmaraezy, A Ismail, AI Abushouk, M Eltoomy… - BMC Cardiovascular …, 2017 - Springer
Background Recently, transcatheter aortic valve replacement (TAVR) has become the
procedure of choice in high surgical risk patients with aortic stenosis (AS). However, its …

Outcomes 2 years after transcatheter aortic valve replacement in patients at low surgical risk

MB Leon, MJ Mack, RT Hahn, VH Thourani… - Journal of the American …, 2021 - jacc.org
Background In low surgical risk patients with symptomatic severe aortic stenosis, the
PARTNER 3 (Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low …